Clinical Trials Browser

Phase 3 × Active not recruiting × Fluid Therapy × Clear all

NCT03267433 2026-03-02

Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission

Phase 3 Active not recruiting

Lymphoma, Mantle-Cell